S H Kelkar and Company Limited (SHK) - Net Assets
Based on the latest financial reports, S H Kelkar and Company Limited (SHK) has net assets worth Rs13.30 Billion INR (≈ $143.85 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs28.05 Billion ≈ $303.38 Million USD) and total liabilities (Rs14.75 Billion ≈ $159.53 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SHK asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs13.30 Billion |
| % of Total Assets | 47.42% |
| Annual Growth Rate | 10.72% |
| 5-Year Change | 33.3% |
| 10-Year Change | 77.7% |
| Growth Volatility | 18.72 |
S H Kelkar and Company Limited - Net Assets Trend (2011–2025)
This chart illustrates how S H Kelkar and Company Limited's net assets have evolved over time, based on quarterly financial data. Also explore SHK current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for S H Kelkar and Company Limited (2011–2025)
The table below shows the annual net assets of S H Kelkar and Company Limited from 2011 to 2025. For live valuation and market cap data, see S H Kelkar and Company Limited stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs12.72 Billion ≈ $137.61 Million |
+4.80% |
| 2024-03-31 | Rs12.14 Billion ≈ $131.31 Million |
+10.12% |
| 2023-03-31 | Rs11.03 Billion ≈ $119.25 Million |
+0.82% |
| 2022-03-31 | Rs10.94 Billion ≈ $118.27 Million |
+14.57% |
| 2021-03-31 | Rs9.55 Billion ≈ $103.23 Million |
+14.38% |
| 2020-03-31 | Rs8.35 Billion ≈ $90.25 Million |
-4.53% |
| 2019-03-31 | Rs8.74 Billion ≈ $94.54 Million |
+2.01% |
| 2018-03-31 | Rs8.57 Billion ≈ $92.67 Million |
+5.56% |
| 2017-03-31 | Rs8.12 Billion ≈ $87.79 Million |
+13.36% |
| 2016-03-31 | Rs7.16 Billion ≈ $77.44 Million |
+69.63% |
| 2015-03-31 | Rs4.22 Billion ≈ $45.65 Million |
-11.47% |
| 2014-03-31 | Rs4.77 Billion ≈ $51.57 Million |
+1.01% |
| 2013-03-31 | Rs4.72 Billion ≈ $51.05 Million |
+25.47% |
| 2012-03-31 | Rs3.76 Billion ≈ $40.68 Million |
+23.05% |
| 2011-03-31 | Rs3.06 Billion ≈ $33.06 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to S H Kelkar and Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3107.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs9.03 Billion | 70.98% |
| Common Stock | Rs1.38 Billion | 10.88% |
| Other Components | Rs2.31 Billion | 18.14% |
| Total Equity | Rs12.72 Billion | 100.00% |
S H Kelkar and Company Limited Competitors by Market Cap
The table below lists competitors of S H Kelkar and Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nuvectis Pharma Inc
NASDAQ:NVCT
|
$218.75 Million |
|
Cantabil Retail India Limited
NSE:CANTABIL
|
$218.77 Million |
|
GalaxiaMoneytree Co.Ltd
KQ:094480
|
$218.78 Million |
|
Signature International Bhd
KLSE:7246
|
$218.79 Million |
|
Nitco Limited
NSE:NITCO
|
$218.72 Million |
|
Ziprecruiter Inc
NYSE:ZIP
|
$218.71 Million |
|
TMC Life Sciences Bhd
KLSE:0101
|
$218.66 Million |
|
Medical Facilities Corporation
TO:DR
|
$218.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in S H Kelkar and Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,128,100,000 to 12,719,600,000, a change of 591,500,000 (4.9%).
- Net income of 732,400,000 contributed positively to equity growth.
- Dividend payments of 103,800,000 reduced retained earnings.
- Other comprehensive income decreased equity by 1,334,900,000.
- Other factors increased equity by 1,297,800,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs732.40 Million | +5.76% |
| Dividends Paid | Rs103.80 Million | -0.82% |
| Other Comprehensive Income | Rs-1.33 Billion | -10.49% |
| Other Changes | Rs1.30 Billion | +10.2% |
| Total Change | Rs- | 4.88% |
Book Value vs Market Value Analysis
This analysis compares S H Kelkar and Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 9.46x to 1.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | Rs15.44 | Rs146.12 | x |
| 2012-03-31 | Rs26.01 | Rs146.12 | x |
| 2013-03-31 | Rs32.50 | Rs146.12 | x |
| 2014-03-31 | Rs33.72 | Rs146.12 | x |
| 2015-03-31 | Rs29.84 | Rs146.12 | x |
| 2016-03-31 | Rs52.49 | Rs146.12 | x |
| 2017-03-31 | Rs56.13 | Rs146.12 | x |
| 2018-03-31 | Rs59.31 | Rs146.12 | x |
| 2019-03-31 | Rs60.50 | Rs146.12 | x |
| 2020-03-31 | Rs59.06 | Rs146.12 | x |
| 2021-03-31 | Rs68.95 | Rs146.12 | x |
| 2022-03-31 | Rs73.75 | Rs146.12 | x |
| 2023-03-31 | Rs78.74 | Rs146.12 | x |
| 2024-03-31 | Rs88.43 | Rs146.12 | x |
| 2025-03-31 | Rs92.22 | Rs146.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently S H Kelkar and Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.76%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.47%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 2.11x
- Recent ROE (5.76%) is below the historical average (11.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 14.10% | 6.88% | 0.66x | 3.08x | Rs91.52 Million |
| 2012 | 10.95% | 7.26% | 0.79x | 1.90x | Rs35.71 Million |
| 2013 | 12.64% | 8.98% | 0.86x | 1.64x | Rs124.76 Million |
| 2014 | 16.62% | 10.44% | 0.88x | 1.81x | Rs315.84 Million |
| 2015 | 16.68% | 8.45% | 0.92x | 2.14x | Rs282.08 Million |
| 2016 | 10.20% | 7.92% | 0.92x | 1.41x | Rs14.55 Million |
| 2017 | 12.91% | 10.75% | 0.91x | 1.33x | Rs236.46 Million |
| 2018 | 10.96% | 9.21% | 0.80x | 1.49x | Rs81.90 Million |
| 2019 | 10.25% | 8.50% | 0.72x | 1.67x | Rs21.45 Million |
| 2020 | 4.33% | 3.23% | 0.74x | 1.81x | Rs-467.07 Million |
| 2021 | 15.20% | 11.00% | 0.69x | 1.99x | Rs495.29 Million |
| 2022 | 14.66% | 9.53% | 0.68x | 2.27x | Rs472.40 Million |
| 2023 | 5.75% | 3.65% | 0.75x | 2.09x | Rs-452.68 Million |
| 2024 | 10.09% | 6.68% | 0.76x | 1.98x | Rs11.39 Million |
| 2025 | 5.76% | 3.47% | 0.79x | 2.11x | Rs-539.56 Million |
Industry Comparison
This section compares S H Kelkar and Company Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $8,233,598,031
- Average return on equity (ROE) among peers: 14.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| S H Kelkar and Company Limited (SHK) | Rs13.30 Billion | 14.10% | 1.11x | $218.74 Million |
| Aarti Industries Limited (AARTIIND) | $16.55 Billion | 20.11% | 1.65x | $1.99 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.11 Billion | 1.88% | 1.36x | $37.34 Million |
| ABM International Limited (ABMINTLLTD) | $161.33 Million | 4.08% | 2.02x | $4.23 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $1.66 Billion | 30.02% | 1.39x | $420.87 Million |
| Aether Industries Limited (AETHER) | $22.26 Billion | 7.12% | 0.19x | $1.68 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $9.20 Billion | 20.25% | 0.96x | $1.45 Billion |
| Alkali Metals Limited (ALKALI) | $528.67 Million | 5.51% | 1.00x | $7.38 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $980.47 Million | 17.95% | 1.88x | $838.56 Million |
| Ami Organics Limited (AMIORG) | $576.82 Million | 32.06% | 1.70x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $29.31 Billion | 4.39% | 0.57x | $1.65 Billion |
About S H Kelkar and Company Limited
S H Kelkar and Company Limited, together with its subsidiaries, manufactures and supplies fragrances, flavors, and aroma ingredients in India. Its fragrances are used in personal care, fabric care, skin care, hair care, fine fragrances, and home care products, as well as flavors are used in baked, dairy, beverages, savoury, and pharmaceutical products. The company is also involved in microbiology… Read more